RetroSearch Browse

Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/29580641/ below:

Status of HPV vaccine introduction and barriers to country uptake

. 2018 Aug 6;36(32 Pt A):4761-4767. doi: 10.1016/j.vaccine.2018.02.003. Epub 2018 Mar 23. Status of HPV vaccine introduction and barriers to country uptake

Affiliations

¹ London School of Hygiene & Tropical Medicine, Clinical Research Department, UK.
² PATH, Centre for Vaccine Innovation & Access, Seattle, USA. Electronic address: slamontagne@path.org.
³ London School of Hygiene & Tropical Medicine, Clinical Research Department, UK; Mwanza Intervention Trials Unit, Mwanza, Tanzania.

PMID: 29580641
DOI: 10.1016/j.vaccine.2018.02.003

Free article

Item in Clipboard

Status of HPV vaccine introduction and barriers to country uptake

K E Gallagher et al. Vaccine. 2018.

Free article . 2018 Aug 6;36(32 Pt A):4761-4767. doi: 10.1016/j.vaccine.2018.02.003. Epub 2018 Mar 23. Affiliations

¹ London School of Hygiene & Tropical Medicine, Clinical Research Department, UK.
² PATH, Centre for Vaccine Innovation & Access, Seattle, USA. Electronic address: slamontagne@path.org.
³ London School of Hygiene & Tropical Medicine, Clinical Research Department, UK; Mwanza Intervention Trials Unit, Mwanza, Tanzania.

PMID: 29580641
DOI: 10.1016/j.vaccine.2018.02.003

Item in Clipboard

Abstract

During the last 12 years, over 80 countries have introduced national HPV vaccination programs. The majority of these countries are high or upper-middle income countries. The barriers to HPV vaccine introduction remain greatest in those countries with the highest burden of cervical cancer and the most need for vaccination. Innovation and global leadership is required to increase and sustain introductions in low income and lower-middle income countries.

Keywords: HPV; Human papillomavirus; Low income countries; Uptake; Vaccine.

PubMed Disclaimer

Cited by

Planning, implementation, and sustaining high coverage of human papillomavirus (HPV) vaccination programs: What works in the context of low-resource countries?
Waheed DE, Bolio A, Guillaume D, Sidibe A, Morgan C, Karafillakis E, Holloway M, Van Damme P, Limaye R, Vorsters A. Waheed DE, et al. Front Public Health. 2023 Apr 14;11:1112981. doi: 10.3389/fpubh.2023.1112981. eCollection 2023. Front Public Health. 2023. PMID: 37124764 Free PMC article. Review.

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3